Market Overview

Reoxygenation Injury Drug Development Pipeline Analysis Report 2018 - ResearchAndMarkets.com

Share:

The "2018
Reoxygenation Injury Drug Development Pipeline Analysis Report-
Companies, Drugs, Clinical Trials, Latest Developments in Reoxygenation
Injury Market"
report has been added to ResearchAndMarkets.com's
offering.

Reoxygenation Injury is a heart related condition in which blood supply
is restored to the tissue after some period of ischemia or absence of
oxygen supply. The new supply causes additional complications such as
inflammation, innate immunity, and oxidative stress instead of restoring
regular function.

To assist researchers, investors and business development managers, the
publisher has come up with a comprehensive report on Reoxygenation
Injury pipeline. The report provides insights into different therapeutic
candidates in preclinical, research, discovery, NDA/IND, pre
registration, phase 1, phase 2, and phase 3 trials. Drugs under
development directly and through combination with other drugs are also
included.

Current status, developmental phase, participating companies and
entities, recent developments, orphan drug/ fast track/ other
designations, drug class are provided for each Reoxygenation Injury
pipeline product. Mechanism of Action and the target area of the
pipeline product are also provided. Further, clinical and preclinical
trials along with results of the trials are also included in the report.

In addition to complete details of each product, the report provides key
trends in Reoxygenation Injury pipeline studies. The products under
development are categorized according to their development phase,
mechanism and company to provide detailed insights into the type of
drugs being developed and the stages of development.

Companies Mentioned

  • Angion Biomedica Corp
  • Armaron Bio Pty Ltd
  • BioMedCore Inc
  • Bolder Biotechnology Inc
  • Catalyst Biosciences Inc
  • Celdara Medical LLC
  • CFM Pharma Holding BV
  • Corline Biomedical AB
  • Faraday Pharmaceuticals
  • Glucox Biotech AB
  • Ischemix Inc
  • MallInckrodt Plc
  • Miragen Therapeutics Inc
  • NovelMed Therapeutics Inc
  • Opsona Therapeutics Ltd
  • Pharming Group NV
  • Prolong Pharmaceuticals LLC
  • Prothix BV
  • Radikal Therapeutics Inc
  • SBI Pharmaceuticals Co Ltd
  • TheraSource LLC
  • TRIM-edicine Inc
  • X-In8 Biologicals Corp
  • List Continues.

Key Topics Covered:

1 Table of Contents

2 Reoxygenation Injury Pipeline Analysis

3 Reoxygenation Injury- Company Wise Pipeline Analysis

4 Reoxygenation Injury R&D Pipeline Snapshots

5 Recent Developments in Reoxygenation Injury Pipeline

6 Appendix

For more information about this report visit https://www.researchandmarkets.com/research/2n29rc/reoxygenation?w=4

View Comments and Join the Discussion!